Novartis Reported Encouraging Trial Data for a Multiple Sclerosis Drug. The Stock Is Jumping

Promising results from a recent clinical trial are boosting Novartis shares this morning.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。